11 September 2018
Using mathematical modelling, researchers within the Applied Diagnostics Research and Evaluation Unit at the university concluded that a bespoke point-of care diagnostic device could significantly reduce the number of return clinical visits and the average time-to-cure from about a week to one day.
The research team were working with Aquarius Population Health on the project.
At present, sexual health clinics assess arriving patients with a questionnaire. After symptoms are examined by a clinician, 'presumptive treatment' is given, usually antibiotics, on the basis of an initial diagnosis. However, until lab results are returned, there is no way of knowing if that diagnosis is correct.
Professor Tariq Sadiq of St George's explained: "A multiple STI test device is all about enabling specific treatment for the correct infection. The device that is being proposed would be a 4 pathogen test, for Chlamydia, Gonorrhea, Trichomonas vaginalis and Mycoplasma genitalium. According to our research not only would this cut treatment time, it would almost halve the existing rates of onward transmission to partners."
The device is in early phases of development by Atlas Genetics Limited, following a grant from from Innovate UK via the Small Business Research Initiative. Innovate grants are given to small businesses to encourage collaboration with academic researchers.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024